Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

European Society For Medical Oncology

ESMO-Immuno-Oncology-2024-1000x250-Register-Now
Early registration deadline 9 October 2024
Early registration deadline 9 October 2024

See you in Geneva or Online

Learn about recent developments on immune modulation, including tumour microenvironment, immunometabolism, epigenetics or microbiome

Register now and save!
ESMO-MCBS 1000x1000

ESMO-MCBS

A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.

Discover more

Latest News

Read the ESMO Daily Reporter
Guidelines News Guidelines News

Rare Endocrine Tumours: ESMO Clinical Practice Guideline

This new CPG covers the management of neuroendocrine neoplasms of the head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms, with recommendations on imaging, diagnosis, treatment and follow-up based on scientific data and collective expertise from across Europe

Read the ESMO Daily Reporter More Oncology News More Press Releases More Society Updates
More Oncology News
Press Releases ESMO Congress 2024 Press Release

Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group of Women with Early-Stage Disease

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found ‘promising’ antitumour activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily pretreated patients with ovarian and endometrial cancers

Press Releases ESMO Congress 2024 Press Release

From Practice-Changing Data to Future Innovation, Patient Outcomes to Doctors’ Wellbeing, the ESMO Congress 2024 Takes a Holistic View of Oncology

The ESMO Congress 2024 taking place 13-17 September in Barcelona, Spain, offers a comprehensive view of the current drug development landscape, with existing medicines demonstrating benefit in additional applications and new agents emerging in large numbers as the range of potential molecular targets for therapy continues to expand

Press Releases Media Alert

ESMO 2024 Press Conference

The ESMO Congress 2024 will hold a press conference to introduce and discuss the “Eyes to the Future” Presidential Symposium 3, that will be presenting prominent approaches that have the potential to become increasingly effective and influential components of cancer treatment in the (near) future.

Press Releases ESMO Congress 2024 Press Release

Studies Provide First Evidence That Breastfeeding after Breast Cancer Is Safe

According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation (an inherited change in BRCA genes that significantly increases the risk of developing certain cancers, especially breast cancer), do not face an increased risk of recurrence or developing new breast cancers

Press Releases ESMO Gynaecological Cancers Congress 2024 Press Release

Cross-Border Network of European Specialists Provides New Treatment Options For Women with Complex Rare Gynaecological Cancers

Cross-border tumour boards of cancer specialists from different European countries meeting virtually to review the management of individual patients with complex rare gynaecological cancers from across Europe resulted in new treatment recommendations and increased access to clinical trials, according to results from a six-year study that will be presented at the ESMO Gynaecological Cancers Congress 2024

More Press Releases
Society Updates

ESMO Congress 2024: Five Days of Science Dissemination and Education

Bringing another annual reunion of the global oncology community to a resounding close, the 34,000 attendees of the ESMO Congress 2024 had the opportunity to gather around to listen to the most important results presented in different tumour types and research areas

Society Updates Society Updates

New ESMO President 2027-2028 Elected

ESMO has announced today the results of its Presidential elections following the closure of the voting system on Monday, 10 June 2024.

Society Updates Society Updates

Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive

Following the Ombudsman’s recent findings of maladministration regarding the Commission’s interactions with tobacco lobbyists and its subsequent decision not to bring forward the proposed Council recommendation on smoke-free environments, it is beyond belief that the Commission now appears to have removed plans to publish an evaluation – originally meant to come in 2022 - of the Tobacco Products Directive from its implementation

More Society Updates

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.